Revenue
No reported data
Boundless Bio, Inc. (BOLD)
Price—Loading quote
Net income
2023
2024
2025
Free cash flow
2023
2024
2025
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Research & development | $44.8M | $55.3M | $42.6M |
| Operating expenses | $63.6M | $73.3M | $54.8M |
| Operating income | −$63.6M | −$73.3M | −$54.8M |
| EBITDAderived | −$62.3M | −$72.2M | −$53.8M |
| Net income | −$58.2M | −$65.4M | −$49.4M |
| Basic EPSper diluted share | -$2.60 | -$3.85 | -$40.65 |
| Diluted EPSper diluted share | -$2.60 | -$3.85 | -$40.65 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 29, 2026Form 4 | TANG KEVIN +1TenPercentOwner | BuyCommon Stock · indirect | 777 | $2.48 | $1.9K | 2.53M |
| Jun 29, 2026Form 4 | TANG KEVIN +1TenPercentOwner | BuyCommon Stock · indirect | 64.0K | $2.47 | $158.0K | 2.53M |
| Jun 26, 2026Form 4 | TANG KEVIN +1TenPercentOwner | BuyCommon Stock · indirect | 134 | $2.54 | $340.36 | 2.47M |
| Jun 26, 2026Form 4 | TANG KEVIN +1TenPercentOwner | BuyCommon Stock · indirect | 75.0K | $2.55 | $191.4K | 2.47M |
| Jun 25, 2026Form 4 | TANG KEVIN +1TenPercentOwner | BuyCommon Stock · indirect | 510 | $2.56 | $1.3K | 2.39M |